Orgenesis (ORGS) Short Interest Ratio & Short Volume → Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (From American Alternative) (Ad) Free ORGS Stock Alerts $0.50 -0.02 (-3.83%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Orgenesis Short Interest DataCurrent Short Volume299,700 sharesPrevious Short Volume322,200 sharesChange Vs. Previous Month-6.98%Dollar Volume Sold Short$246,353.40Short Interest Ratio / Days to Cover1.9Last Record DateMarch 31, 2024Outstanding Shares34,340,000 sharesPercentage of Shares Shorted0.87%Today's Trading Volume34,800 sharesAverage Trading Volume218,907 sharesToday's Volume Vs. Average16% Short Selling Orgenesis ? Sign up to receive the latest short interest report for Orgenesis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatORGS Short Interest Over TimeORGS Days to Cover Over TimeORGS Percentage of Float Shorted Over Time Ad Behind the MarketsWill this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> Orgenesis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024299,700 shares $246,353.40 -7.0%N/A1.9 $0.82 3/15/2024322,200 shares $254,280.24 +42.8%N/A2.2 $0.79 2/29/2024225,700 shares $144,493.14 -7.4%N/A1.5 $0.64 2/15/2024243,800 shares $117,024.00 +61.6%N/A1.7 $0.48 1/31/2024150,900 shares $47,382.60 +25.2%N/A1.6 $0.31 1/15/2024120,500 shares $36,029.50 -36.4%N/A1.3 $0.30 Get the Latest News and Ratings for ORGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023189,500 shares $94,882.65 +47.0%N/A2.4 $0.50 12/15/2023128,900 shares $63,844.17 -39.3%N/A1.8 $0.50 11/30/2023212,300 shares $97,997.68 -12.2%N/A3.4 $0.46 11/15/2023241,900 shares $133,045.00 +21.5%N/A2.4 $0.55 10/31/2023199,100 shares $135,407.91 -18.7%0.8%1.8 $0.68 10/15/2023244,800 shares $206,537.76 +18.4%1.0%2.5 $0.84 9/30/2023206,800 shares $128,216.00 -29.0%0.9%2.1 $0.62 9/15/2023291,400 shares $201,066.00 +45.4%1.2%3.1 $0.69 8/31/2023200,400 shares $102,023.64 +2.4%0.9%2.3 $0.51 8/15/2023195,700 shares $192,568.80 +8.6%N/A4.4 $0.98 7/31/2023180,200 shares $196,418.00 -13.3%N/A6.5 $1.09 7/15/2023207,900 shares $270,270.00 -7.2%N/A7.1 $1.30 6/30/2023224,100 shares $311,499.00 +13.6%N/A7.4 $1.39 6/15/2023197,200 shares $256,360.00 -1.0%N/A5.5 $1.30 5/31/2023199,100 shares $236,929.00 +6.9%N/A4.4 $1.19 5/15/2023186,300 shares $199,359.63 -11.5%N/A2.4 $1.07 4/30/2023210,600 shares $231,660.00 -43.4%N/A2.8 $1.10 4/15/2023372,100 shares $427,915.00 -17.2%N/A5 $1.15 3/31/2023449,600 shares $530,528.00 +47.5%N/A5.9 $1.18 3/15/2023304,800 shares $377,952.00 -19.1%1.3%4.3 $1.24 2/28/2023376,800 shares $542,592.00 +91.0%1.6%6.3 $1.44 2/15/2023197,300 shares $420,249.00 +0.4%1.0%3.4 $2.13 1/31/2023196,600 shares $471,840.00 -12.7%1.0%1.8 $2.40 1/15/2023225,100 shares $535,738.00 +2.4%1.1%2 $2.38 12/30/2022219,800 shares $428,610.00 +4.9%1.0%2 $1.95 12/15/2022209,500 shares $427,380.00 -5.1%1.0%1.9 $2.04 11/30/2022220,800 shares $441,600.00 -25.9%1.0%2.1 $2.00 11/15/2022298,000 shares $643,680.00 +53.8%1.4%2.9 $2.16 10/31/2022193,800 shares $259,692.00 +2.1%0.9%1.8 $1.34 10/15/2022189,900 shares $241,173.00 -4.7%0.8%5.1 $1.27 9/30/2022199,300 shares $283,006.00 +28.5%0.9%5.8 $1.42 9/15/2022155,100 shares $285,384.00 -9.9%0.7%4.8 $1.84 8/31/2022172,200 shares $334,068.00 +13.1%0.8%5.1 $1.94 8/15/2022152,300 shares $284,801.00 -10.4%0.7%4.2 $1.87Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW ORGS Short Interest - Frequently Asked Questions What is Orgenesis' current short interest? Short interest is the volume of Orgenesis shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 299,700 shares of ORGS short. Learn More on Orgenesis' current short interest. What is a good short interest ratio for Orgenesis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ORGS shares currently have a short interest ratio of 2.0. Learn More on Orgenesis's short interest ratio. Is Orgenesis' short interest increasing or decreasing? Orgenesis saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 299,700 shares, a decline of 7.0% from the previous total of 322,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Orgenesis' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Orgenesis: Benitec Biopharma Inc. (0.47%), Minerva Neurosciences, Inc. (0.74%), FSD Pharma Inc. (2.06%), KALA BIO, Inc. (0.25%), VBI Vaccines Inc. (1.30%), NeuroSense Therapeutics Ltd. (0.70%), Flora Growth Corp. (13.36%), Galecto, Inc. (0.16%), Alaunos Therapeutics, Inc. (9.90%), Talphera, Inc. (0.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Orgenesis stock? Short selling ORGS is an investing strategy that aims to generate trading profit from Orgenesis as its price is falling. ORGS shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Orgenesis? A short squeeze for Orgenesis occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ORGS, which in turn drives the price of the stock up even further. How often is Orgenesis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORGS, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Benitec Biopharma Short Interest Minerva Neurosciences Short Interest FSD Pharma Short Interest KALA BIO Short Interest VBI Vaccines Short Interest NeuroSense Therapeutics Short Interest Flora Growth Short Interest Galecto Short Interest Alaunos Therapeutics Short Interest Talphera Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORGS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders